Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Albireo Pharma Inc
About ALBO
Albireo Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its product, Bylvay, is for the treatment of pruritis in patients with progressive familial intrahepatic cholestasis (PFIC) ages three months or older and is authorized in Europe for the treatment of PFIC in patients ages six months or older. Its product candidate elobixibat is licensed for the treatment of chronic constipation and other functional diseases in Japan and other select markets in Asia. Its lead candidate for adult liver diseases, A3907, is a selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) where systemic bioavailability has been demonstrated in preclinical and clinical studies. Its preclinical candidate for adult viral and liver diseases includes A2342.
Find out what a historical investment in Albireo Pharma Inc would be worth today using our ALBO stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy ALBO shares in Australia?
Buying ALBO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Albireo Pharma Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ALBO
What is the ticker symbol of Albireo Pharma Inc?
The ticker symbol for Albireo Pharma Inc is ALBO.
How much is one share of ALBO?
One share of ALBO is valued at $44.07 as of 21 May 2026.
What is the market capitalisation of Albireo Pharma Inc ALBO?
As of 21 May 2026 Albireo Pharma Inc has a market cap of -.
What is the 52-week high for Albireo Pharma Inc stock?
The Albireo Pharma Inc 52-week high stock price is $NaN.
What is the 52-week low for Albireo Pharma Inc stock?
The Albireo Pharma Inc 52-week low stock price is $NaN.
Can I buy ALBO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ALBO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ALBO on Stake
- Buy ALBO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ALBO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ALBO related stocks